Related by context. All words. (Click for frequent words.) 73 Patients Receiving 72 Renal Cell Carcinoma 71 Prolongs Survival 71 Squamous Cell Carcinoma 71 Chronic Sinusitis 71 ACE Inhibitors 71 Bivalirudin 71 Rheumatoid Arthritis Patients 71 Appears Safe 71 Patients Undergoing 70 Efficacy Trial 70 Nebulized 70 Immunosuppression 70 Patients Treated With 70 Antitumor Activity 70 Disease Progression 70 Fungal Infections 70 Diabetic Foot Ulcers 70 Invasive Breast Cancer 70 B Cell Lymphoma 69 Phase 2b Study 69 Radiofrequency Ablation 69 Investigational Treatment 69 Improves Survival 69 Resistant Hypertension 69 Myelodysplastic Syndromes 69 Demonstrates Efficacy 69 Minimally Invasive Procedure 69 FDA Approvals 69 Allogeneic 69 Pediatric Patients 69 Radioimmunotherapy 69 Malignant Glioma 69 Abciximab 69 Embolization 69 Liver Failure 69 Improves Outcomes 69 Irinotecan 69 Elderly Patients 69 Fondaparinux 69 Low Dose 69 Treating Chronic 69 Severe Sepsis 69 Adjunctive 68 Diabetic Foot Ulcer 68 Metastatic Colorectal Cancer 68 Diabetic Neuropathy 68 Meets Primary Endpoint 68 Mitomycin C 68 Metastatic Melanoma 68 Aliskiren 68 Patients Treated 68 Atypical Hemolytic Uremic Syndrome 68 Survival Benefit 68 Phase 2b Clinical Trial 68 Ischemic 68 Advanced Melanoma 68 Intravascular 68 Beta Blocker 68 Unfractionated Heparin 68 HER2 Positive Breast Cancer 68 Overactive Bladder 68 Efficacious 68 Hepatocellular Carcinoma 68 Beta Blockers 68 Treated Patients 68 Initiate Clinical Trial 68 Prophylactic Treatment 67 Fluorouracil 67 Lung Tumors 67 Peripheral Arterial 67 Hormone Refractory Prostate Cancer 67 Adjuvant Treatment 67 Is Well Tolerated 67 Intravenous Formulation 67 Tumor Response 67 Colorectal Cancer Patients 67 Inhaled Corticosteroids 67 Myelodysplastic Syndrome 67 Dose Ranging Study 67 Neoplasms 67 Coronary Artery Bypass Graft 67 Chronic Heart Failure 67 Anticoagulant 67 radiofrequency ablation RFA 67 Heart Failure Patients 67 Fracture Risk 67 Liver Tumors 67 Diabetic Patients 67 Oral Mucositis 67 Anticoagulants 67 Eculizumab 67 Statistically Significant 67 Androgen Deprivation Therapy 67 Bevacizumab 67 Single Dose 67 Combo Therapy 67 Enlarged Prostate 67 Phase III Clinical Trial 67 Adefovir 67 Catheter Ablation 67 Chemoradiation 67 Myocardial Ischemia 67 cinacalcet 67 Tumor Growth 67 Skeletal Muscle 67 Oral Fingolimod 67 Subcutaneous 67 Peginterferon 67 Study Showed 67 Renal Artery 67 Improve Survival 67 Doxorubicin 67 Contrast Agents 67 Long Term Efficacy 67 Bisphosphonate 67 Lung Cancer Patients 67 Prospective Randomized 67 Combination Treatment 67 Intracerebral 67 metastatic malignant 67 Relapsing Multiple Sclerosis 67 Anthracycline 67 Erlotinib 67 Cryoablation 66 Stenosis 66 Shows Efficacy 66 Improved Survival 66 Pneumococcal Vaccine 66 Gastric Cancer 66 Toxicities 66 thalidomide Thalomid 66 Metastatic Prostate Cancer 66 Aortic Valve 66 Dasatinib 66 Exacerbation 66 Capecitabine 66 Adjuvant Chemotherapy 66 Fludarabine 66 Acute Pancreatitis 66 CT Angiography 66 Antifungal 66 Phase 2b Trial 66 Pulmonary Arterial Hypertension 66 Nilotinib 66 Golimumab 66 Tyrosine Kinase Inhibitor 66 Peginterferon Alfa 2a 66 NAVISTAR R 66 Diabetic Nephropathy 66 Pegylated Interferon 66 Aortic Valve Replacement 66 Non Alcoholic Fatty 66 Naive Patients 66 Replacement Therapy 66 Advanced Colorectal Cancer 66 Breast Cancer Recurrence 66 Bloodstream Infections 66 Relapsing Remitting Multiple Sclerosis 66 Follicular Lymphoma 66 Myelofibrosis 66 Recurrent Breast Cancer 66 Investigational Agent 66 Glioblastoma Multiforme 66 Phase III Trial 66 Thrombotic 66 colorectal liver metastases 66 Azacitidine 66 Renal Impairment 66 Myelodysplastic Syndrome MDS 66 Tiotropium 66 Septic Shock 66 Diuretic 66 Knee Osteoarthritis 66 Hypertensive Patients 66 Trastuzumab 66 Investigational Drug 66 Chronic Renal Failure 66 Tacrolimus 66 Percutaneous Tibial Nerve Stimulation 66 Melphalan 66 Stenting 66 Pivotal Trial 66 Peptic Ulcer 66 Pooled Analysis 66 Urinary Tract Infections 66 Minimally Invasive Treatment 66 Placebo Controlled Study 66 NDA Submission 66 Relapsed Refractory 66 Dendritic Cells 66 Phase IIb Trial 66 Proves Effective 66 Corneal Transplant 66 Effectively Treats 65 Intra arterial 65 Non Invasive Treatment 65 Patency 65 Cancer Treatments 65 Demonstrates Potent 65 Aurora Kinase 65 Cytarabine 65 Intravesical 65 Severe Asthma 65 Therapy Reduces 65 leiomyomas 65 Posaconazole 65 Prostatic 65 Tigecycline 65 Soft Tissue Sarcoma 65 Brain Metastases 65 Non Inferiority 65 Post Operative 65 Carcinoma 65 Thrombin 65 Cystectomy 65 Mitoxantrone 65 Drug Candidate 65 Statin Therapy 65 IND Application 65 Shows Promise Against 65 Sustained Efficacy 65 Drug Resistant 65 Patients Suffering 65 Restenosis 65 Cholesterol Lowering Drug 65 Less Invasive 65 Coronary Arteries 65 Clinical Trial Results 65 Well Tolerated 65 corticosteroid therapy 65 Bazedoxifene 65 Malignant Melanoma 65 Potentially Fatal 65 Clinical Outcome 65 Cisplatin 65 Spinal Fusion 65 Monotherapy 65 Novel Oral 65 Pivotal Study 65 Left Ventricular 65 Immunomodulatory 65 Inflammatory Markers 65 Prostate Cancer Treatment 65 Refractory Hodgkin Lymphoma 65 Pemetrexed 65 Carotid Stenting 65 Stomach Cancer 65 Sustained Reduction 65 Phase IIb Clinical Trial 65 Decitabine 65 Bosentan 65 Lung Cancer Survival 65 Acute Ischemic Stroke 65 Epithelial 65 Embolic 65 Hypotension 65 Renal Function 65 Metastases 65 Double Blind Randomized 65 Cell Transplants 65 FDA Okays 65 Blood Pressure Drug 65 Cell Lymphoma 65 Hip Fractures 65 Ranolazine 65 Shows Promising 65 Cyclophosphamide 65 Chemotherapy Regimen 65 Bare Metal Stents 65 Benign Prostatic Hyperplasia BPH 65 Robotic Assisted 65 Rotavirus Vaccine 65 Dual Antiplatelet Therapy 65 Venous Thromboembolism 65 Stereotactic Body Radiation Therapy 65 Intracerebral Hemorrhage 65 Autologous 65 Aneurysm Repair 65 Randomized Clinical Trial 65 Fibrin Sealant 65 Autologous Stem Cell Transplantation 65 Breast Cancer Treatment 65 Interferon Alfa 65 Antitumor 65 Osteoporosis Drugs 65 Malignancies 65 Chronic Myeloid Leukemia 65 Motexafin Gadolinium 65 Heart Transplant Recipients 65 Enoxaparin 65 Infarct 65 Fewer Side Effects 65 Kidney Transplant Patients 65 Juvenile Idiopathic Arthritis 65 Treatment Shows Promise 65 Complicated Skin 65 Corticosteroids 65 Hypercholesterolemia 65 Invasive Fungal Infections 65 Previously Treated 65 Neuroprotective Effects 65 Degarelix 64 Drug Shows Promise 64 Prostate Cancer Patients 64 Infected Patients 64 chemoradiation therapy 64 Postmenopausal Osteoporosis 64 Thiazolidinediones 64 Pivotal Trials 64 ACE Inhibitor 64 Viral Load 64 Acute Heart Failure 64 Kidney Function 64 Hormone Receptor Positive 64 Expanded Indication 64 Gout Drug 64 ARIXTRA R 64 Intravitreal 64 Radiofrequency ablation 64 Progenitor Cells 64 Thromboembolism 64 Liver Injury 64 Adjuvant Therapy 64 Nephrectomy 64 Controlled Study 64 Reduced Risk 64 Insulin Therapy 64 Radiation Dose 64 HoFH 64 Bendamustine 64 Chemotherapy Induced 64 Drug Eluting 64 Cocaine Addiction 64 Immunotherapeutic 64 Aortic Stenosis 64 Secondary Hyperparathyroidism 64 Fluconazole 64 Lenalidomide 64 Thrombus 64 JAK Inhibitor 64 Bosutinib 64 Transdermal Patch 64 Resection 64 Metastatic Renal Cell Carcinoma 64 Skin Lesions 64 Nesiritide 64 Transplant Rejection 64 Parenteral Nutrition 64 Interferon Beta 64 Oral Cavity 64 Leucovorin 64 allogeneic hematopoietic stem cell 64 Ascites 64 Portal Hypertension 64 Nonsurgical 64 Pioglitazone 64 Pegylated 64 Epilepsy Drug 64 Hepatic 64 Idiopathic Pulmonary Fibrosis 64 Drug Combo 64 alfa 2a 64 docetaxel Taxotere ® 64 Sorafenib 64 Paraplatin ® 64 Neoadjuvant 64 Occlusive Disease 64 Mouse Model 64 Tumor Cells 64 Kidney Failure 64 Lupus Nephritis 64 complement inhibitor eculizumab 64 Ischemic Stroke 64 Postherpetic Neuralgia 64 Antiangiogenic 64 Tumor Necrosis Factor 64 Phase 2a Clinical Trial 64 Contrast Agent 64 Therapeutic Vaccine 64 Delayed Graft Function 64 Proven Effective 64 Schizophrenia Treatment 64 Investigational Compound 64 Glatiramer Acetate 64 Platinol ® 64 Pharmacokinetic Study 64 Pivotal Phase 64 operable pancreatic cancer 64 Advanced Renal Cell 64 sorafenib Nexavar 64 INTEGRILIN R 64 Coronary Angiography 64 rFVIIa 64 Potent Anti 64 Demonstrates Positive 64 ThermoDox R 64 Multiple Myeloma Patients 64 Allergic Rhinitis 64 Endometrial Cancer 64 Insulin Glargine 64 Grafts 64 Preclinical Data 64 Duodenal 64 HCV Genotype 64 Immune Responses 64 recurrent glioblastoma multiforme 64 Stent Thrombosis 64 Treatment Reduces 64 abacavir Ziagen 64 Stem Cell Treatment 64 Carotid Artery Stenting 64 Node Positive 64 Cytotoxic 64 MR Angiography 64 Parathyroid Hormone 64 Newly Diagnosed Multiple Myeloma 64 Anticoagulation 64 Abdominal Pain 64 Cutaneous T 64 Myeloma Patients 64 Migraine Headaches 64 Bortezomib 64 Interferon Alpha 64 Shows Statistically Significant 64 Lymphoid 64 metastatic neuroendocrine tumors 64 Tonsillectomy 64 Valsartan 64 Ventilator Associated 64 Zoledronic Acid 64 Azathioprine 64 Randomized Study 64 Hsp# Inhibitor 64 Antiplatelet Therapy 64 Vidaza azacitidine 63 Heart Ailments 63 Transdermal Delivery 63 Regurgitation 63 See CLINICAL PHARMACOLOGY 63 Bone Metastases 63 gastrointestinal stromal tumors GIST 63 Carboplatin Paclitaxel 63 nicardipine 63 Endothelial 63 Partial Nephrectomy 63 Plus Ribavirin 63 Phase III Trials 63 Enzyme Replacement Therapy 63 Recombinant Human 63 First Patient Treated 63 Moxifloxacin 63 Cyclosporine 63 Chronic Prostatitis 63 CYT# potent vascular disrupting 63 Kidney Transplant Recipients 63 Lowers Risk 63 Catheter Associated 63 Attenuates 63 adalimumab Humira 63 Cardiovascular Disease Risk 63 Coronary Artery 63 Demonstrates Significant 63 Shown Effective 63 Squamous 63 Corticosteroid 63 Everolimus 63 invasive aspergillosis 63 Chronic HCV 63 antiplatelet drugs 63 biliary tract cancer 63 Lipolysis 63 azacytidine 63 Surgical Procedures 63 Obese Patients 63 Antibiotic Resistant 63 Liver Metastases 63 Tumor Targeting 63 Pegylated Liposomal Doxorubicin 63 Cilostazol 63 Increased Mortality 63 Coronary Artery Bypass Surgery 63 hyperoxaluria 63 Oxaliplatin 63 Retreatment 63 II Clinical Trial 63 Xelox 63 INFERGEN 63 chronic thromboembolic pulmonary 63 Premature Infants 63 Ureteral 63 pulmonary metastases 63 Oral Formulation 63 Pafuramidine 63 Prophylaxis 63 Renal Anemia 63 Mycophenolate Mofetil 63 Diffuse Large B 63 Cytotoxicity 63 Viral Infection 63 Tyrosine Kinase Inhibitors 63 Phase IIa Clinical Trial 63 Chronic Pelvic Pain 63 Pivotal Phase III 63 FASLODEX 63 mitomycin C 63 Signaling Pathway 63 Anti Tumor 63 Electrical Stimulation 63 Virtual Colonoscopy 63 Liver transplantation 63 Accelerated Partial Breast Irradiation 63 Breast Cancer Cells 63 5 Fluorouracil 63 Alveolar 63 Epidermal Growth Factor Receptor 63 Drug Prevents 63 HDAC Inhibitor 63 BANZEL 63 Treatment Naive Patients 63 Renal Cancer 63 CLINICAL PHARMACOLOGY 63 Biphasic 63 Chronic Myelogenous Leukemia 63 Intracoronary 63 Antiviral Therapy 63 Hemorrhagic Stroke 63 Camptosar ® 63 Osteoporosis Treatment 63 Left Ventricular Hypertrophy 63 Vandetanib 63 Fulvestrant 63 Advanced Prostate Cancer 63 FDA Accepts 63 Pivotal Clinical Trial 63 overactive bladder syndrome 63 Immunosuppressant 63 Neovascular Age Related Macular 63 Pazopanib 63 Blood Clots 63 Symptom Relief 63 ara C 63 malignant ascites 63 Stereotactic Radiosurgery 63 Sipuleucel T 63 Gastrointestinal Stromal Tumors 63 Anticancer Activity 63 Candida infection 63 Clinical Efficacy 63 Induction Therapy 63 FOLFOX6 63 Breast Cancers 63 Gum Disease 63 Aerosolized 63 Hydroxyurea 63 Slow Progression 63 Percutaneous 63 Natalizumab 63 Leukemias 63 Small Intestine 63 Solid Tumors 63 Patient Outcomes 63 metastatic malignant melanoma 63 Hepatotoxicity 63 Diabetic Ulcers 63 Hepatocellular Carcinoma HCC 63 benign neoplasms 63 Linezolid 63 Peritoneal 63 Novel Antibiotic 63 Therapeutic Effects 63 Pharmacodynamics 63 Castration Resistant Prostate Cancer 63 Bone Marrow Transplants 63 cranial irradiation 63 Clinical Trial Evaluating 63 Phase 2a Trial 63 Combination Therapy 63 Liposomal 63 Immune Mediated 63 Achieves Primary Endpoint 63 Reduces Mortality 63 Noxafil 63 Patient Enrollment 63 Inhaled Nitric Oxide 63 erlotinib Tarceva ® 63 Epratuzumab 63 Relapsed Multiple Myeloma 63 dual endothelin receptor antagonist 63 Cardiotoxicity 63 ST Segment Elevation 63 Multiple Myeloma MM 63 Hematopoietic Stem Cells 63 Adenomas 63 Preterm Delivery 63 Antiplatelet 63 Gallbladder 63 Endometrial 63 Cinacalcet 63 Lupus Drug 63 Surgical Treatment 63 Esophageal 63 Successfully Completes Phase 63 Higher Doses 63 Controlled Trial 63 Myocardial Perfusion Imaging 63 Gemcitabine 63 Organ Rejection 63 interferon ribavirin 63 Kidney Stones 63 Topical Treatment 63 Critical Limb Ischemia 63 Rheumatoid 63 nephrotoxicity 63 Proteasome 63 Dupuytren Contracture 63 Percutaneous Transluminal Coronary Angioplasty 62 Adenoviral 62 Antibiotic Treatment 62 Pertuzumab 62 Adjuvant 62 Study Evaluating 62 Adjuvant chemotherapy 62 Implantable Cardioverter Defibrillator 62 Carcinomas 62 Levels Linked 62 Hepatic Encephalopathy 62 Lesion 62 cytoreductive surgery 62 Postmenopausal 62 Endothelial Cell 62 Dose Escalation 62 Bacteremia 62 Enzastaurin 62 Premenopausal Women 62 Blocked Arteries 62 Placebo Controlled Trial 62 endometrial hyperplasia 62 Rheumatoid Arthritis Drug 62 Intubation 62 Microalbuminuria 62 Dacogen decitabine 62 Retinoic Acid 62 Hepatitis B Vaccine 62 PICSO ® 62 Receives Orphan Drug Designation 62 anticholinergic agents 62 Anticancer Drug 62 ClearPath HDR 62 Nucleoside 62 Meta Analysis 62 Microplasmin 62 Erectile Dysfunction Drug 62 Genital Herpes 62 Pharmacokinetics PK 62 Ovarian Cancers 62 Adenocarcinoma 62 Antiepileptic Drug 62 Adult Stem Cell Therapy 62 Prognostic Factors 62 Estrogen Receptor 62 alkylating agent 62 fosbretabulin 62 renal artery stenting 62 Acute Myocardial Infarction 62 Stakeholder Opinions 62 Recurrent Stroke 62 Ventricular Tachycardia 62 Bronchoscopy 62 Therapeutic Efficacy 62 Critically Ill Patients 62 invasive candidiasis 62 Significantly Improved 62 Protease Inhibitor 62 Myoblast 62 Hematopoietic 62 Papillary 62 Genes Linked 62 nimodipine 62 Gleevec resistant 62 Cloretazine 62 Acute Decompensated Heart Failure 62 Atopic Dermatitis 62 Lung Cancer Treatment 62 Novel Inhibitor 62 Data Suggest 62 Rectal Cancer 62 Chronic Hepatitis B 62 Danazol 62 Neulasta ® 62 Postmarketing 62 Artery Disease 62 MGd 62 ß blockers 62 Valvular 62 Lamotrigine 62 Lymph Node 62 LDL Cholesterol 62 Thromboembolic 62 Partial Onset Seizures 62 bevacizumab Avastin 62 Cardiovascular Events 62 Bare Metal Stent 62 Randomized Evaluation 62 Insulin Sensitivity 62 Biliary 62 Fixed Dose 62 Irritable Bowel 62 Sirolimus Eluting Stent 62 Dabigatran 62 Ovarian Cancer Patients 62 Surgical resection 62 FDA Approves Drug 62 Multicenter Trial 62 pancreatectomy 62 Beneficial Effects 62 Progressive Multifocal Leukoencephalopathy 62 Localized Prostate Cancer 62 Targeted Therapy 62 Osteomyelitis 62 occlusive disease 62 Bleomycin 62 Protein Linked 62 liver resection 62 Sapacitabine 62 Occlusion 62 Platelet Inhibition 62 Taxane 62 TACE 62 Benign Prostatic Hyperplasia 62 VAPRISOL 62 Eluting Stent 62 Angioedema 62 Orally Active 62 Primary Hypercholesterolemia 62 Cyclooxygenase 2 62 Cognitive Impairment 62 Carotid 62 Image Guided 62 NMIBC 62 platelet inhibitor 62 Pulmonary Artery 62 Adjunctive Therapy 62 TAXOTERE R 62 Analytical Tool 62 transarterial chemoembolization 62 Anti Inflammatory Drug 62 Synthetic Peptide 62 Uterine Fibroids 62 infusional 62 Esophageal Cancer 62 Etanercept 62 Endothelial Cells 62 Excessive Sweating 62 Metastatic Disease 62 metastatic colorectal 62 Kinase Inhibitor 62 Contrast Enhanced 62 carmustine 62 Non Alcoholic Steatohepatitis 62 Glucocorticoid 62 Paclitaxel Carboplatin 62 Uterine Cancer 62 Breast Tumors 62 Treating Heart Failure 62 Novel Treatments 62 Diabetic Neuropathic Pain 62 Kinase Inhibitors 62 Bladder Cancer 62 Cancer Recurrence 62 FUSILEV enhances 62 Viral Suppression 62 Uric Acid 62 Ablation 62 Osteoporosis Drug 62 Chronic Hepatitis C 62 Stomatitis 62 Phase Ib Clinical Trial 62 Fingolimod 62 adenomatous 62 Risedronate 62 Subgroup Analysis 62 Deforolimus 62 Neoadjuvant Chemotherapy 62 ISTODAX ® 62 recombinant tissue plasminogen 62 Treatment Naïve Patients 62 Universal Flu Vaccine 62 Potent Inhibitor 62 Tumor Cell 62 Amniotic Fluid 62 Non Responders 62 leukemia AML 62 Suicidality 62 thrombocytosis 62 Vertebroplasty 62 Adverse Event 62 Blood Thinner 62 Sevelamer 62 Combination Clinical Trial 62 Bacterial Vaginosis 62 Community Acquired Pneumonia 62 Lung Cancer Trial 62 Hernia Repair 62 Pharmacologic 62 Treat Heart Failure 62 basiliximab 62 Critical Limb Ischemia CLI 62 Intravenous immunoglobulin 62 Hematopoietic Stem Cell Transplantation 62 Prolongs Life 62 Treatment Regimen 62 Anaplastic 62 Epilepsy Drugs 62 Regimens 62 Phase III Pivotal Trial 62 Hyperlipidemia 62 Cardiovascular Outcomes 62 Atypical Antipsychotic 62 Cryosurgery 62 urothelial carcinoma 62 urography 62 Hepatitis C Genotype 62 Brain Aneurysms 62 vorinostat 62 Deep Venous Thrombosis 62 Unstable Angina 62 Aflibercept 62 Hematologic 62 Vertebral Compression Fractures 62 Uterine Fibroid Embolization 62 GW# [003] 62 Left Atrial 62 Radiation Induced 62 5 fluorouracil leucovorin 62 Cardiac Ablation 62 Acute Renal Failure 62 COPD Exacerbations 61 Virus Infection 61 Lubiprostone 61 Herpes Zoster 61 hypervascular tumors 61 Abatacept 61 Plaque Psoriasis 61 REMINDER ORLive Presents 61 Metastatic Pancreatic Cancer 61 Blood Cancers 61 Balloon Angioplasty 61 Smallpox Vaccine 61 Safinamide 61 Refractory Angina 61 PROCRIT R 61 Total Knee Replacement 61 Systolic Blood Pressure 61 hepatorenal syndrome 61 Prognostic Significance 61 Pain Medications 61 Dengue Virus 61 Renal Failure 61 Hemolysis 61 Antacids 61 Showed Significant 61 Reduces Pain 61 neointimal hyperplasia 61 Dilatation 61 Successfully Treated 61 Previously Untreated 61 denileukin diftitox 61 Demonstrates Sustained 61 Embolic Protection Device 61 Successfully Treats 61 Slows Progression 61 Skin Structure Infections 61 liposomal amphotericin B 61 Metastatic 61 Contralateral 61 Gliadel Wafer 61 RNAi Therapeutic 61 Ischaemic 61 Endovascular Treatment 61 unresectable tumors 61 Remission Maintenance 61 Genetic Mutation 61 Tezampanel 61 Gene Mutation 61 Mitral Regurgitation 61 Teriparatide 61 infliximab Remicade 61 Dose Escalation Study 61 Antiviral Drugs 61 benign prostatic hypertrophy BPH 61 GP IIb IIIa inhibitors 61 Breast Cancer Patients 61 symptomatic benign prostatic 61 Intra Arterial 61 Angiographic 61 Anti Tumor Activity 61 Treatment Resistant 61 Anticonvulsant 61 Montelukast 61 Losartan 61 Antiviral Activity 61 Diastolic Heart Failure 61 Thymic 61 Acute Myocardial 61 Regenerative Cells 61 Efficacy Study 61 Peripheral Artery Disease 61 Allograft 61 Skin Cancers 61 Acute Attacks 61 transarterial 61 Arrhythmias 61 Chronic Constipation 61 Confirmatory Phase 61 Antibiotic Use 61 Adenoma 61 transcranial Doppler ultrasound 61 MRSA Infections 61 Unresectable 61 Effective Treatments 61 Pancreatic 61 Chemotherapeutic Agents 61 Reperfusion Injury 61 relapsed MM 61 Oropharyngeal Candidiasis 61 Disease Modifying 61 Interferon Gamma 61 Blood Clot Risk 61 Iron Deficiency 61 Intracranial 61 LHRH 61 Mucosal 61 Who Underwent 61 Alequel 61 Cellular Immunotherapy 61 Aggressive Prostate Cancer 61 HER2 Positive 61 Urinary Incontinence 61 Fibroblast 61 Factor VIIa 61 Intensity Modulated 61 Fabry Disease 61 Lung Cancers 61 Lung Cancer Drug 61 Pleural 61 Cell Lymphoma CTCL 61 direct thrombin inhibitors 61 antiangiogenic therapy 61 MYCAMINE 61 Subtypes 61 Stent Restenosis 61 Aprotinin 61 Systemic Sclerosis 61 liver metastasis 61 Significantly Improves 61 Demonstrate Significant 61 Antitumor activity 61 Lung Injury 61 Bacterial Infections 61 Medoxomil 61 Preclinical Study 61 Osteoarthritis Patients 61 Treatable 61 Receptor Antagonists 61 DMARDS 61 de novo kidney transplant 61 Intraperitoneal 61 Pain Relievers 61 Doxil ® 61 Inhaled 61 Tolerability 61 Fibrinogen 61 Nodules 61 atypical Hemolytic Uremic Syndrome 61 icatibant 61 Infliximab 61 Atomoxetine 61 Transplant Patients 61 steroid refractory 61 Afib 61 micafungin 61 Efficacy Results 61 Prostate Biopsy 61 Stress Urinary Incontinence 61 Fluticasone 61 Receptor Agonist 61 STRIDE PD 61 lenalidomide dexamethasone 61 Granulocyte Colony Stimulating Factor 61 Telithromycin 61 cytoreduction 61 sunitinib Sutent 61 vWF 61 Neuroprotection 61 Kidney Injury 61 galiximab 61 tigecycline 61 Bone Fracture